South Korea's DT&CRO Expands Production Capacity
South Korea's DT&CRO Expands Production Capacity
KOFU, JAPAN--March 14, 2023--Researched by Industrial Info Resources (Sugar Land, Texas)--DT&CRO Company Limited (Gyeonggi-do), a contract research organization (CRO), is expanding its production capacity through a series of facility expansions this year.
The expansion of a non-clinical trial center for studying toxicity entails expanding existing buildings and will be completed by next year, and the expansion of a pharmacokinetics (PK) and pharmacodynamics (PD) center involves adding a new building.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.